Trium Capital’s Zoetis ZTS Stock Holding History

Trium Capital’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,863	Closed	-$858K	–	69
2025 Q3	$858K	Buy	+5,863	New	+$886K	0.34%	31

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Trium Capital's ZTS Position: Q4 2025 in Review

Trium Capital sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 5,863 shares — an estimated $858K sold.

Trium Capital first reported a position in ZTS in Q3 2025 and held it in 1 quarter. The position peaked at $858K in Q3 2025. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

Trium Capital reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
Trium Capital sold 5,863 Zoetis shares in Q4 2025, an estimated $858K.
Trium Capital first reported a position in Zoetis in Q3 2025 and held it in 1 quarter.
Trium Capital's Zoetis position peaked at $858K in Q3 2025.
1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Trium Capital's 13F filing for Q4 2025, filed 22 Jan 2026.